Stay updated on Bedaquiline and Delamanid Combo in DR-TB Clinical Trial
Sign up to get notified when there's something new on the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page.

Latest updates to the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page
- CheckyesterdayChange DetectedAdded a Locations section with Western Cape entries and updated the page revision to v3.3.3, removing the prior Western Cape Locations and HHS Vulnerability Disclosure references (v3.3.2).SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and may not be about the study. The revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check36 days agoChange DetectedThe general government funding/operating status notice was removed; study details, contacts, and eligibility criteria remain accessible.SummaryDifference0.3%

- Check58 days agoChange DetectedOnly minor UI refinements and small text/date updates were observed on the Study Details page, with no substantive changes to core study content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check79 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference2%

- Check86 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.0%

Stay in the know with updates to Bedaquiline and Delamanid Combo in DR-TB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page.